 Pacific Biosciences of California Inc NASDAQ: PACB has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. Under the terms of the agreement, PacBio will acquire Omniome for an upfront payment of 600 million consisting of 9.4 million PacBio shares and 300 million in cash, plus an additional 200 million as milestone payments. 